Global Artificial Pancreas Market to Grow at a CAGR of 15.0% during 2018-2026

Global Artificial Pancreas Market to Grow at a CAGR of 15.0% during 2018-2026

“Artificial Pancreas Market”
New analysis from GMI Research, expects the global Artificial Pancreas Market was valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of 15.0% during 2018–2026.

Artificial pancreas is a device specially designed to release insulin according to the changes in the blood glucose levels. An artificial pancreas device monitors glucose level in the body, automatically adjusts the delivery of insulin to reduce high blood glucose levels and minimizes the incidence of low blood glucose.  

The Global Artificial Pancreas market is primarily driven by the increasing incidences of diabetes patients, growing awareness among the patients about the disease, innovations and technological advancement in diabetes care devices, increasing patients’ disposable income and government insurance coverage. Furthermore, increasing the adoption of the artificial pancreas at hospitals, rising technological advancement and spending on healthcare facilities across the globe will drive the growth of the diabetes care devices over the forecast period.

Request Sample Report of Global Artificial Pancreas Market

Hybrid device type is anticipated to lead the market during 2019-2026 due to the growing innovations and technological advancement in insulin monitoring and delivery technology. Bi Hormonal product type is projected to grow at a higher growth rate during the forecast period owing to the increasing adoption of Bi Hormonal artificial pancreas among healthcare professionals and patients due to its numerous remarkable benefits such as technologically advanced properties.

Hospital segment is expected to grow at the highest CAGR during the forecast period owing to the continuous advancements in the diabetes care industry, increasing prevalence rate of diabetes disease and the increasing research & development activities. Artificial Pancreas is a disruptive product in the field of diabetes care devices as it offers continuous monitoring of insulin in the blood and auto-delivery of insulin to reduce high blood glucose levels. Moreover, the improved healthcare infrastructure and the presence of skilled doctors will further boost the demand of the Artificial Pancreas market over the coming years.

Know more about the Global Artificial Pancreas Market

Players, such as Abbot Laboratories, Medtronic and Boston Scientific Corporation are hugely investing in the research & development activities. The companies are focusing on continuous product innovation in order to capture a higher market share in the Artificial Pancreas Market. For instance, more than 7 products are in the clinical pipeline phase for diabetes disease across the globe.

North America captured the largest market share in the Global Artificial Pancreas Market in 2018 owing to increasing government and private funding on healthcare infrastructure, rising diagnosis rate of diabetes and growing incidences of diabetic patients. Asia Pacific is expected to grow at a higher CAGR during the forecast years owing to the rising number of patients suffering from diabetes caused by the changing lifestyle, genetic drift or modification, growing urbanization, and aging factors. Over the forecast years, escalating incidences of diabetes disease are anticipated to sustain market growth. As per NCBI published article, Asia-Pacific countries contribute to approximately more than 60% to the global diabetic population, supporting the growth of the artificial pancreas market in the region during the forecast period.

Major key players in the Global Artificial pancreas market include Abbott Laboratories, Becton Dickinson and Company, Bayer Healthcare, Roche Holding AG, Medtronic plc, Dexcom Inc, Biotronik SE & GlaxoSmithKline, and others.

The global artificial pancreas market has been segmented based on product type, end-user and key geographies. Based on product type, the market comprises of insulin, bi-Hormonal and hybrid. The end-user segment includes clinics, hospitals and others and key geographical regions.


Our Other Related Reports:

Global Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring Devices and Insulin Delivery Devices), by End User (Hospitals, Homecare Setting and Others) and by Geography – Opportunities & Forecast 2018-2025 –


About GMI Research:

GMI Research is a market research & consulting firm which helps its client to address their most pressing strategic and business challenges. Our market research helps our clients to address business challenges and also helps them to make better business decisions with our fact-based insights, intelligence, and data. Our insights and intelligence equip our clients with information not known to them and aid them in solving the toughest business problems. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomic factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: Send Email
Phone: +1 860 881 2270
City: Dublin
Country: Ireland